Zantac is pulled from shelves in the UK

Mail Online | 10/8/2019 | Stephen Matthews Health Editor For Mailonline;Connor Boyd Health Reporter For Mailonline;Jack Elsom For Mailonline
ditranian (Posted by) Level 3
Click For Photo:

The manufacturer of common heartburn drug Zantac has recalled several batches over fears they could contain a cancer-causing chemical.

GlaxoSmithKline announced four different types of the medication, all only available on prescription, would be recalled.

Over-the-counter - Zantac - Products - People - Prescription

Over-the-counter Zantac products, which people can buy without a prescription, are made by a different pharmaceutical firm and are not affected by the recall.

It is feared some pills may contain traces of NDMA, or N-nitrosodimethylamine - considered to be 'probably carcinogenic' to humans.

Health - Chiefs - UK - Today - Companies

Health chiefs in the UK today told companies to stop supplying the affected Zantac products immediately and quarantine all remaining stock.

The Medicines and Healthcare products Regulatory Agency (MHRA), which polices the safety of drugs in the UK, issued the alert.

Patients - Medication - Doctor

But it said patients should keep taking their medication unless told otherwise by their doctor.

Dr Andrew Gray, MHRA's deputy director of inspections, enforcement and standards, said: 'Whilst this action is precautionary, the MHRA takes patient safety very seriously.

'Patients - Medicines - Doctor - Pharmacist - Doctor

'Patients should keep taking their current medicines but should speak to their doctor or pharmacist if they are concerned and should seek their doctor’s advice before stopping any prescribed medicines.

'We have asked companies to quarantine batches of potentially affected medicines whilst we investigate and we will take action as necessary, including product recalls where appropriate.

'We - Risk - Assessments - Relevant - Companies

'We have also requested risk assessments from the relevant companies which will include the testing of potentially affected batches.

In Ireland, 13 products containing ranitidine, the main ingredient in Zantac, were recalled two days later on September 26.

Equivalent - MHRA - Health - Products - Regulatory

The Irish equivalent to the MHRA - the Health Products Regulatory Authority - said the...
(Excerpt) Read more at: Mail Online
Wake Up To Breaking News!
Sign In or Register to comment.

Welcome to Long Room!

Where The World Finds Its News!